# insitro hires a chief medical officer as its first liver-disease drugs head for trials in early 2027

Canonical page: https://technooptimist.io/stories/insitro-hires-a-chief-medical-officer-as-its-first-liver-disease-drugs-a85b6022
Date: 8 Sep 2026
About: [insitro](https://technooptimist.io/companies/insitro.md) · [ML-driven target discovery](https://technooptimist.io/biotech/insitro-platform.md)
Original source: https://www.insitro.com/news/insitro-appoints-hideo-makimura-as-chief-medical-officer-to-lead-its-transition-to-a-clinical-stage-company/

insitro named Hideo Makimura chief medical officer to lead its move to human trials. It says programs aimed at genetic drivers of liver fat and scarring will enter the clinic in early 2027, out of nine first-in-class programs that also include an ALS therapy.

---

The Techno Optimist tracks every frontier of technology, program by program: https://technooptimist.io/ (a Markdown version of any page: add .md to its URL; site map for agents: https://technooptimist.io/llms.txt).
Data API (JSON, realtime stream): https://technooptimist.io/developers. People read 5 pages free, then Reader $10/month; these Markdown pages are open to agents.